-
Broad SARS-CoV-2 neutralization by monoclonal and bispecific antibodies derived from a Gamma-infected individual
Guerra, D., Beaumont, T., Radić, L., Kerster, G., van der Straten, K., Yuan, M., Torres, J. L., Lee, W-H., Liu, H., Poniman, M., Bontjer, I., Burger, J. A., Claireaux, M., Caniels, T. G., Snitselaar, J. L., Bijl, T. P. L., Kruijer, S., Ozorowski, G., Gideonse, D., Sliepen, K., & 6 others , 20 Oct 2023, In: iScience. 26, 10, 108009.Research output: Contribution to journal › Article › Academic › peer-review
-
Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study
COBRA KAI Study Team, 1 Jul 2023, In: EClinicalMedicine. 61, 102040.Research output: Contribution to journal › Article › Academic › peer-review
-
Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses
Radić, L., Sliepen, K., Yin, V., Brinkkemper, M., Capella-Pujol, J., Schriek, A. I., Torres, J. L., Bangaru, S., Burger, J. A., Poniman, M., Bontjer, I., Bouhuijs, J. H., Gideonse, D., Eggink, D., Ward, A. B., Heck, A. J. R., van Gils, M. J., Sanders, R. W. & Schinkel, J., 21 Apr 2023, In: iScience. 26, 4, 106540.Research output: Contribution to journal › Article › Academic › peer-review
- All publications